Bionano Genomics Inc (BNGO.xnas)

Bionano Genomics Inc (BNGO.xnas)

Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Bionano Genomics Inc (BNGO.xnas) Profile

Bionano Genomics Inc (BNGO.xnas) is a genome analysis company providing Saphyr platform with tools and services to analyse the long segments of genomic DNA headquartered in California, America. Bionano company does extensive genetic research, patient testing, and diagnosing testing for autism spectrum disorder and other neurodevelopmental disabilities and offers proprietary nanochannel chips and automated imaging instrument. Bionano’s platform Saphyr provides ultra-sensitive and ultra-specific structural variation detection that enables scientists and clinicians to accelerate the search for new diagnostics and therapeutic targets and streamline the study of chromosome changes. Bionano Genomics employs 180 people and has a market capitalisation of $1.05B (USD) as of December 2021. The Bionano Genomics Inc stock (BNGO.xnas) is listed on NASDAQ and has a $4.7M (USD) in 2021 revenue. The Bionano is the parent company of BioDiscovery and Lineagen and has 3 offices in 3 countries. Bionano Genomics Inc is making major improvements with the Saphyr platform, with a record number of Saphyr shipments and saw a big increase of 122% year-over-year in the sale of nanochannel array flow cells used with the instrument. The company released Bionano Solve version 3.7 and Bionano Access version 1.7 as available data solution upgrades for Saphyr systems installed in laboratories worldwide and as of November 2021.

Holding cost
Trading hours in US Eastern Time

Start Trading Bionano Genomics Inc (BNGO.xnas)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

6 Reasons to Trade Share
CFDs with FP Markets

An Australian-regulated
forex & CFD broker

Go Long or Short

Increase your ability to profit in all market conditions Leverage options up to 20:1

Direct Market Access (DMA) Execution

Real-time, transparent share prices Control, Functionality and deep liquidity Full Market depth & see your orders in the queue

Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

24/5 Multilingual
Customer Support

Award winning support & personal account managers

Global Exposure

Low margins and competitive commission +10,000 products on global stocks across 4 continents

Earn Dividends

On long positions No ownership of physical shares necessary

Start Trading
in Minutes

Open an account now

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.

Get instant Updates in Telegram
Sitemap | © FP Markets 2022